Shopping Cart
- Remove All
Your shopping cart is currently empty
AB-680, a highly potent, reversible, and selective inhibitor of CD73 (an ectonucleotidase, Ki: 4.9 pM for hCD73) with anti-tumor activity, displays >10,000-fold selectivity over related ectonucleotidases CD39.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $115 | In Stock | |
| 2 mg | $163 | In Stock | |
| 5 mg | $247 | In Stock | |
| 10 mg | $393 | In Stock | |
| 25 mg | $658 | In Stock | |
| 50 mg | $937 | In Stock | |
| 100 mg | $1,270 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $316 | In Stock |
| Description | AB-680, a highly potent, reversible, and selective inhibitor of CD73 (an ectonucleotidase, Ki: 4.9 pM for hCD73) with anti-tumor activity, displays >10,000-fold selectivity over related ectonucleotidases CD39. |
| Targets&IC50 | CD73:4.9 pM (ki;human), CD73:43 pM (Soluble hCD73) |
| In vitro | AB-680 inhibits soluble hCD73 (IC50: 0.043 nM), also inhibits hCD73 in CHO cells, suppresses CD73 in human, mouse CD8+ T Cells and hPBMC, with IC50s of 0.070, 0.008, 0.66 and 0.011 nM, respectively. |
| Molecular Weight | 580.82 |
| Formula | C20H24ClFN4O9P2 |
| Cas No. | 2105904-82-1 |
| Smiles | N([C@@H](C)C1=C(F)C=CC=C1)C2=C3C(N(N=C3)[C@@H]4O[C@H](COP(CP(=O)(O)O)(=O)O)[C@@H](O)[C@H]4O)=NC(Cl)=C2 |
| Relative Density. | 1.86 g/cm3 (Predicted) |
| Storage | store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 180 mg/mL (309.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (8.61 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.